Article tools
Author information
Published in Volume 98, Issue 9 (November 1,1996)
J. Clin. Invest. 98(9): 2100-2108 (1996). doi:10.1172/JCI119016.
Copyright © 1996, The American Society for Clinical Investigation.

Research Article

A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

S Tanaka and J R Wands

Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown 02129, USA.

Published November 1, 1996

Insulin receptor substrate-1 (IRS-1), a substrate of various receptor tyrosine kinases transmits mitogenic signals initiated by extracellular ligands. This protein is involved in normal hepatocyte growth and has been found to be overexpressed in human hepatocellular carcinoma. Expression of a carboxy-terminal truncated IRS-1 molecule containing the pleckstrin homology and phosphotyrosine-binding domains associates with the insulin receptor and prevents tyrosyl phosphorylation of endogenous IRS-1 and Shc proteins. Thus, subsequent activation of downstream signaling molecules induced by insulin and IGF-1 such as phosphatidylinositol-3 kinase and mitogen activated protein kinase is inhibited. The morphologic features of transformed human hepatocellular carcinoma cells change to a differentiated hepatocyte appearance and characteristics of the malignant phenotype as manifested by anchorage independent cell growth and tumor formation in nude mice are lost. These studies demonstrate that signal transduction pathways mediated through or by IRS-1 are important in hepatocyte and human hepatocellular carcinoma cell growth.

This article Copyright © 1996, The American Society for Clinical Investigation.

Articles that cite
this article:

Ethanol Inhibition of Insulin Signaling in Hepatocellular Carcinoma Cells
Kakoli Banerje, Leonhard Mohry, Jack R. Wands, Suzanne M. Monte
Alcohol Clin Exp Res 22(9):2093. [CrossRef]

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
Shinji Tanaka, Masaki Mori, Yoshihiro Sakamoto, Masatoshi Makuuchi, Keizo Sugimachi, Jack R. Wands
J Clin Invest 103(3):341. [CrossRef]

Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms
M. Chiara Cantarini, Suzanne M. De la monte, Maoyin Pang, Ming Tong, Antonia D'errico, Franco Trevisani, Jack R. Wands
Hepatol 44(2):446. [CrossRef]

Synergistic premalignant effects of chronic ethanol exposure and insulin receptor substrate-1 overexpression in liver
Lisa Longato, Suzanne De la monte, Sophia Califano, Jack R. Wands
38(9):940. [CrossRef]

Immunological approach to hepatocellular carcinoma
J. R. Wands, L. Lavaissiere, D. Moradpour, S. Monte, L. Mohr, C. Nicolau, S. Tanaka
J Viral Hepat 4(s2):60. [CrossRef]

Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
S. Tanaka, S. Arii, M. Yasen, K. Mogushi, N. T. Su, C. Zhao, I. Imoto, Y. Eishi, J. Inazawa, Y. Miki
Br J Surg 95(5):611. [CrossRef]

Molecularly targeted therapy for hepatocellular carcinoma
Shinji Tanaka, Shigeki Arii
49(4):133. [CrossRef]

Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma
Shinji Tanaka, Keishi Sugimachi, Hidetoshi Kawaguchi, Hiroshi Saeki, Shinji Ohno, Jack R. Wands, Keizo Sugimachi
J Cell Physiol 183(3):411. [CrossRef]

Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only
Leonhard Mohr, Kakoli Banerjee, Manuela Kleinschmidt, Mara Matilde Bartolom rodrguez, Jack R. Wands
[CrossRef]

Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma
Mark Branda, Jack R. Wands
Hepatol 43(5):891. [CrossRef]

Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma
Daniele Mattera, Gaetano Capuano, Annamaria Colao, Rosario Pivonello, Francesco Manguso, Alessandro Puzziello, Luciano D'agostino
Clin Endocrinol (Oxf) 59(6):699. [CrossRef]

Dysregulation of glycogen synthase kinase-3β signaling in hepatocellular carcinoma cells
Christèle Desbois-mouthon, Marie-José Blivet-van eggelpoë, Eléonore Beurel, Mathieu Boissan, Roland Delélo, Axelle Cadoret, Jacqueline Capeau
Hepatol 36(6):1528. [CrossRef]

Alcohol-Induced Disruption of Endocrine Signaling
Martin J. J. Ronis, Jack R. Wands, Thomas M. Badger, Suzanne M. De la monte, Charles H. Lang, Jan Calissendorff
Alcohol Clin Exp Res 31(8):1269. [CrossRef]

Molecularly targeted therapy for hepatocellular carcinoma
Shinji Tanaka, Shigeki Arii
Cancer Sci 100(1):1. [CrossRef]

Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver
Lisa Longato, Suzanne De la monte, Noriyoshi Kuzushita, Masayoshi Horimoto, Arlin B. Rogers, Betty L. Slagle, Jack R. Wands
Hepatol 49(6):1935. [CrossRef]